+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A pilot study comparing the clinical effects of Jia-Wey Shiau-Yau San, a traditional Chinese herbal prescription, and a continuous combined hormone replacement therapy in postmenopausal women with climacteric symptoms



A pilot study comparing the clinical effects of Jia-Wey Shiau-Yau San, a traditional Chinese herbal prescription, and a continuous combined hormone replacement therapy in postmenopausal women with climacteric symptoms



Maturitas 44(1): 55-62



Objectives: Interest in use of alternative remedies for managing menopausal symptoms is increasing exponentially during these years. Jia-Wey Shiau-Yau San (JWSYS), one of the traditional Chinese herbal prescriptions, is a famous herbal remedy used for the management of various menopausal-related symptoms. A randomized, controlled pilot study was performed to evaluate the clinical effects of JWSYS compared with those of a continuous combined hormone replacement therapy, Premelle(R), on quality of life in non-hysterectomized postmenopausal women. Methods: The present trial compared the effect of a 16-week treatment with JWSYS or HRT (Premelle(R)) in postmenopausal women with climacteric symptoms. The Greene Climacteric Scale was used to assess the clinical effects at baseline and after 16 weeks' treatment with either JWSYS or Premelle(R). The physiological parameters, such as follicle-stimulating hormone and estradiol levels, were also recorded at the same time points. Results: The results showed that JWSYS had a relatively lower discontinuation rate due to adverse effects, in particular the bleeding and breast tenderness. Both JWSYS and Premelle(R) effectively alleviated most of the menopausal symptoms with no significant differences between treatment groups, whereas the beneficial effects of JWSYS were not mediated by hormone replacement-like effects. Moreover, JWSYS showed a good compliance and safety without estrogenic effects and metabolic alterations. Conclusions: It was suggested that JWSYS was a safe and efficacious therapy and might be an alternative choice for relief of climacteric symptoms in postmenopausal women. However, the exact efficacy and clinical roles of JWSYS have not been convincingly demonstrated in this study because of the blinding approach and some statistical concerns, and only the possibility of its efficacy has been raised. Therefore, a blinding trial with more patient numbers to evaluate the efficacy of JWSYS deserves further study.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010086496

Download citation: RISBibTeXText

PMID: 12568736

DOI: 10.1016/s0378-5122(02)00314-6


Related references

Economic impact of the physician/nurse substitution in community health care sector. Revue de l'Infirmiere 2002(85): 20-23, 2002

Economic growth and the quality of the environment: Taking stock. Environment, Development and Sustainability 9(4): 427-454, 2007

A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy. European Journal Of Cancer. 32a(5): 807-813, 1996

Continuous colorimetric screening assay for detection of d-amino acid aminotransferase mutants displaying altered substrate specificity. Analytical Biochemistry 463: 23-30, 2014

A randomised, double-blind trial comparing mibefradil and amlodipine: two long-acting calcium antagonists with similar efficacy but different tolerability profiles. Mibefradil International Study Group. Journal of Human Hypertension 11(6): 387-393, 1997

Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report. Indian Journal of Physiology and Pharmacology 51(2): 183-188, 2008

Clinical, lipid and angiographic predictors of progression and regression of coronary atherosclerosis. European Heart Journal 16(ABSTR Suppl. ): 463, 1995

Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis. Journal of Clinical Endocrinology and Metabolism 89(2): 626-631, 2004

Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma. Scandinavian Journal of Gastroenterology 41(9): 1095-1104, 2006

Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells. Journal of the Formosan Medical Association 99(2): 140-150, 2000

Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women. Maturitas 15(3): 225-232, 1992

Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60. Obstetrics and Gynecology 95(1): 104-110, 2000

Effects of simvastatin a new lipoprotein lowering drug on the hepatic drug metabolism enzymes among the wistar rat. Therapie (London/Paris) 45(1), 1990

Bleeding pattern in HRT regimens with continuous estradiol valerate and sequential chlormadinone acetate. Maturitas 27(Suppl. ): 114, 1997

Continuous versus bolus thermodilution cardiac output measurements: A comparative study. Critical Care Medicine 23(5): 944-949, 1995